fenofibrate and bicyclol

fenofibrate has been researched along with bicyclol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Dong, H; Fong, WF; Ko, KM; Pan, SY; Wang, H; Xiang, CJ; Yu, ZL; Zhao, XY1

Other Studies

2 other study(ies) available for fenofibrate and bicyclol

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice.
    The Journal of pharmacy and pharmacology, 2007, Volume: 59, Issue:12

    Topics: Analysis of Variance; Animals; Bile Acids and Salts; Biphenyl Compounds; Cholesterol; Cholesterol, Dietary; Cyclooctanes; Dose-Response Relationship, Drug; Fenofibrate; Hypercholesterolemia; Hypolipidemic Agents; Intubation, Gastrointestinal; Lipids; Liver; Male; Mice; Mice, Inbred ICR; Tablets; Time Factors; Triglycerides

2007